Obstetrics & Gynecology Doctors in Fort Leonard Wood, MO Accepting Medicare

2 Obstetrics & Gynecology doctors found. Showing 1 - 2

Dr. Leah Swanzy Scarlotta, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4430 Missouri Ave, Fort Leonard Wood, MO 65473 Phone: 713-594-6936

Dr. Keane Emile Mccullum, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4430 Missouri Ave, Fort Leonard Wood, MO 65473 Phone: 573-596-1770

News Archive

Review of transplant issues in patients with biliary atresia

The most common indication worldwide for pediatric transplantation, biliary atresia is also the most common cause of chronic liver disease in newborns.

How can we predict the number of future COVID-19 hospital admissions?

Research led by Sophie Meakin of the London School of Hygiene & Tropical Medicine in the United Kingdom suggests ensemble forecasts — a method combining multiple models to predict COVID-19 cases — may be more accurate in estimating COVID-19 hospital admissions in local areas.

Pennsylvania House approves bill allowing young adults to remain on parents' health insurance policies up to age 29

The Pennsylvania House last week voted to approve a bill that allows state residents up to age 29 to be added to or remain on their parents' health insurance plans as long as they live in the state or are full-time students, the Harrisburg Patriot-News reports. They also must be single and not have dependents.

Slavica BioChem scientists reverse multidrug resistance in lung cancer using small molecules

HTDS - The issuer's Serbia based operating subsidiary Slavica BioChem www.slavicabiochem.com brings attention to its Mindup Bioresearch cancer project working on molecular origins of lung cancer: prospects for personalized prevention and therapy. On October 8 2009, the company posted a filing on Pink Sheets titled MindUp Cancer Project.

FDA removes clinical hold on HEPLISAV hepatitis B vaccine

Dynavax Technologies Corporation today announced that the U.S. Food and Drug Administration (FDA) has removed the clinical hold for the HEPLISAVTM Investigational New Drug (IND) application in individuals with chronic kidney disease.

Read more Medical News

› Verified 9 days ago